Original Research
Accepted on 08 May 2026
Real-world Efficacy of Eculizumab in Generalized Myasthenia Gravis Patients with Poor Early Response to Efgartigimod: A Prospective Cohort Study
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders